Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
94.3 CHF | -0.68% |
|
+1.69% | +11.11% |
Jun. 07 | Abu Dhabi, Novartis to Collaborate on Genomics Research for Cancer Therapy | MT |
Jun. 07 | Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.11% | 216B | |
+47.36% | 765B | |
-6.16% | 354B | |
+20.37% | 331B | |
+9.51% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+5.08% | 164B | |
-2.22% | 162B | |
+0.57% | 123B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation